Hepatitis Council of QLD

Hepatitis Council of Queensland Inc.
Home arrow Hepatitis News

News Disclaimer

news.jpg The following news items are automatic news feeds from other websites.The Hepatitis Council of Queensland (HCQ) does not endorse and is not responsible for the content of these news items.

For more news, check out our C-network email news bulletin service.
 
 
 
Hepatitis News
MedWorm: Hepatitis C
MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest headlines from journals and sites in the Hepatitis C category.

  • Terrence Higgins Trust Re-Launches Support Group For Gay Men With Hepatitis C And HIV, UK
    On Thursday 12 August, Terrence Higgins Trust (THT) will be running another six week course for gay men who are living with HIV and Hepatitis C. The group will meet each week from 6.30 - 9.30pm in central London. The course looks at living with both HIV and Hepatitis C, but the primary focus will be on Hepatitis. Issues covered include dealing with the impact of diagnosis, the medical aspects of Hepatitis C, treatment, sex and disclosure and coping emotionally. The course will be run by someone with personal experience of HIV and Hepatitis C... (Source: Health News from Medical News Today)

    MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.



  • Clinical and Biologic Importance of F-Actin Autoantibodies in HCV Monoinfected and HCV-HIV Coinfected Patients.
    Authors: Hudacko RM, Alvarez GA, Talal AH, Jacobson I, Wan DW, Zhou XK, Yantiss RK The purpose of this study was to evaluate the relationship between serum filamentous (F)-actin antibody titers and severity of hepatitis present in hepatitis C virus (HCV)-infected patients. Liver biopsy samples from 18 HCV monoinfected and 20 HCV-HIV coinfected patients were graded with respect to the degree of hepatitis activity and intensity of plasma cell infiltration using MUM-1 and CD138 immunostains. Of the 38 HCV-infected patients, 6 (16%) had F-actin antibody titers in excess of 30 enzyme-linked immunosorbent assay units. We found a positive trend between serum F-actin antibody levels and the mean number of plasma cells present in the portal tracts of patients with HCV infection (r = 0.31; P = ....

  • Terrence Higgins Trust re-launches support group for gay men with Hepatitis C and HIV
    On Thursday 12 August, Terrence Higgins Trust (THT) will be running another six week course for gay men who are living with HIV and Hepatitis C. The group will meet each week from 6.30 - 9.30pm in central London. The course looks at living with both HIV and Hepatitis C, but the primary focus will be on Hepatitis. Issues covered include dealing with the impact of diagnosis, the medical aspects of Hepatitis C, treatment, sex and disclosure and coping emotionally.The course will be run by someone with personal experience of HIV and Hepatitis C. A doctor and a clinical nurse from Chelsea and Westminster Hospital will lead sessions on treatment and the medical side of things. Gordon Mundie, Groupwork Service Manager at Terrence Higgins Trust said “Living with HIV and Hepatitis C can be tough ...

  • Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial Of PSI-938 In Patients With Chronic Hepatitis C
    This study is designed to assess the safety, tolerability and antiviral activity of PSI-938 monotherapy administered over 7 days in HCV-infected individuals... (Source: Health News from Medical News Today)

  • Consumer Information on: OraQuick HCV Rapid Antibody Test - P080027
    The OraQuick HCV Rapid Antibody Test is used to detect a patient?s exposure to the hepatitis C virus (HCV). Antibodies are proteins produced by the body to fight against foreign substances, such as viruses and bacteria. The presence of the antibodies... (Source: Food and Drug Adminstration (FDA): CDRHNew)

  • OraQuick HCV Rapid Antibody Test
    The OraQuick HCV Rapid Antibody Test is used to detect a patient?s exposure to the hepatitis C virus (HCV). Antibodies are proteins produced by the body to fight against foreign substances, such as viruses and bacteria. The presence of the antibodies... (Approved: 6/25/2010) (Source: Medical Device Approvals)

    MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.



  • Novel Hepatitis C Treatments Gets A Leg Up From The Increasing Number Of Diagnosed Cases, Finds Frost & Sullivan
    The Singaporean government's emphasis on raising awareness on the benefit of frequent health check-ups have significantly raised the number of Hepatitis C Virus (HCV) diagnosed cases in the country, expanding the patient pool. Therapeutics companies have a challenging task ahead for improving treatment for this market as current treatment requires high dosage frequency, but potentially has serious side effects... (Source: Health News from Medical News Today)

  • Clinical Trials Update: July 27, 2010
    Iron Deficiency Anemia Hepatitis C Rheumatoid Arthritis (Source: The Doctors Lounge - Health News)

  • Doctors call for ban on multidose vials after hepatitis C outbreak in US
    (Source: BMJ Online First)

  • Hepatitis C Virus-related Chronic Liver Disease in Elderly Patients: an Italian Cross-sectional Study
    This new study explores the prevalence of chronic hepatitis C among the elderly population Journal of Viral Hepatitis (Source: Medscape Today Headlines)

  • Interleukin-10 gene polymorphisms in association with susceptibility to chronic hepatitis C virus infection: a meta-analysis study
    In conclusion, this meta-analysis suggested that the IL-10 −1082GG genotype was associated with increased susceptibility for chronic HCV infection. Content Type Journal ArticleCategory Brief ReportDOI 10.1007/s00705-010-0757-2Authors Li-Zhou Zhang, Anhui Medical University Department of Infectious Diseases, The First Affiliated Hospital 218 Jixi Road Hefei 230022 Anhui ChinaTian-Chen Zhang, Anhui Medical University Department of Epidemiology and Biostatistics, School of Public Health 81 Meishan Road Hefei 230032 Anhui ChinaFa-Ming Pan, Anhui Medical University Department of Epidemiology and Biostatistics, School of Public Health 81 Meishan Road Hefei 230032 Anhui ChinaZhen-Hua Zhang, Anhui Medical University Department of Infectious Diseases, The First Affiliated Hospital 218 Jix...

    MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.



  • 2010 Annual Evidence Update on Hepatitis B and C - Introduction
    NHS Evidence Annual Evidence Updates (AEUs) attempt to draw together recently published, high quality evidence – focusing particularly on systematic reviews and published guidelines - which it is hoped will inform and enhance the decision making and planning of clinicians, commissioners and others involved in the process of health care. For this Hepatitis B and C AEU updating last year's work, a detailed literature search from 2009-2010 identified 246 potential pieces of evidence (see methods for retrieving and evaluating the evidence for more information). Following a process of filtering and peer review (with thanks to the reviewers listed below) 61 of these form the basis of this AEU. It is imperative that those involved in commissioning and delivering care are apprised of the best av...

  • Salivary Hypofunction in Chronic Hepatitis C Infection
    Chelsia Sim, Norah Terrault, Norah Terrault, Nita Chainiani Wu, Ava Wu. University of California, San Francisco (Source: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics)

  • Merck Grants License to LabCorp for Development of Test To Potentially Identify Patients Likely to Respond to Hepatitis C Therapy
    (Source: Merck.com - Corporate News)

  • Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma
    Conclusion Interferon treatment after curative resection or ablation of HCC in HCV-related cirrhotics prevents HCC recurrence and improves survival. (Source: Alimentary Pharmacology and Therapeutics)

  • A study on the association with hepatitis B and hepatitis C in 1557 patients with lichen planus
    Conclusion Lichen planus is associated with hepatitis C but not with hepatitis B. Physicians who care for patients with lichen planus should consider screening patients with lichen planus for hepatitis C. (Source: Journal of the European Academy of Dermatology and Venereology)

    MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.



  • Use of Gloves and Reduction of Risk of Injury Caused by Needles or Sharp Medical Devices in Healthcare Workers: Results from a Case‐Crossover Study
    Conclusions. Although the use of gloves reduces the risk of sharps injuries in health care, use among healthcare workers is inconsistent and may be influenced by risk perception and healthcare culture. Glove use should be emphasized as a key element of multimodal sharps‐injury reduction programs. (Source: Infect Control Hosp Epidemiol Latest Issue)

  • Depression May Compromise Treatment for Hepatitis C Virus
    Symptoms of major depression in patients with hepatitis C virus are often missed during routine clinical interviews, and the presence of depression hinders treatment outcomes; in addition, hepatitis C virus is associated with greater absence from work, lower productivity, and higher health care costs, according to two articles published in the August issue of Hepatology. (Source: Modern Medicine)

  • Hepatitis Virus Transmission Through Misuse Of Anesthesia
    In this study, doctors found that anesthesia contamination - not endoscopy contamination - was the cause of infection. Efforts are needed to better educate the health-care community on the importance of strict adherence to sterile techniques when using any form of anesthesia... (Source: Health News from Medical News Today)

  • Disturbances of parathyroid hormone–vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study
    ConclusionsVitamin D inadequacy and the severity of liver dysfunction move in parallel in patients with non-cholestatic CLD. Vitamin D assessment and replacement should be considered in the management of patients with non-cholestatic CLD. Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9194-2Authors Arash Miroliaee, Tehran University of Medical Sciences Department of Gastroenterology, Imam Hospital Tehran IranMohsen Nasiri-Toosi, Tehran University of Medical Sciences Department of Gastroenterology, Imam Hospital Tehran IranOmid Khalilzadeh, Tehran University of Medical Sciences Department of Gastroenterology, Imam Hospital Tehran IranAlireza Esteghamati, Tehran University of Medical Sciences Endocrinology and Metabolism Research Center (E...